AWKN — Awakn Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Awakn Life Sciences, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.

	2021 January 31st	2022 January 31st	2023 January 31st	2024 January 31st
Period Length:	—	—	—	—
Source:	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.366	1.62	0.551	0.407
Net Total Accounts Receivable
Net Total Receivables	0.018	0.13	0.143	0.021
Prepaid Expenses
Total Current Assets	0.477	2.11	0.975	0.496
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.349	3.61	2.95	0.001
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.825	6.88	4.39	0.543
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.242	1.86	2.46	2.07
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	0.498	3.46	3.55	2.07
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.328	3.41	0.848	-1.53
Total Liabilities & Shareholders' Equity	0.825	6.88	4.39	0.543
Total Common Shares Outstanding